Status:

UNKNOWN

Cardiac Responsiveness Assessment by CO2

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

VCO2 Variation in Intensive Care as a Marker of Fluid Responsiveness

Cardiac Index Variation Transpulmonary Thermodilution in Patients on Controlled Ventilation With Shock

Eligibility:

All Genders

10+ years

Brief Summary

The increase of cardiac output resulting from increased blood volume (systolic ejection volume) during intravenous fluid administration defines a state of fluid responsiveness. Fluid responsiveness i...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patient hospitalized in intensive care.
  • Patient sedated and mechanically ventilated in Volume Assisted Controlled mode.
  • Patient with hypotension (MAP \<65 mmHg OR SAP \<90 mmHg) AND / OR under continuous infusion of Norepinephrine / Dobutamine / Epinephrine
  • Patient equipped with a cardiac output measurement system by transpulmonary thermodilution (PICCO®) with a femoral arterial module; as well as a central venous route in the superior or inferior vena cava territory.
  • Exclusion Criteria :
  • Patient under 18 years old
  • Patient under guardianship without the possible consent of the guardian
  • Pregnant woman
  • Pathologies and maneuvers strongly affecting CO2 purification: Diagnosed pulmonary embolism, Prone positioning for less than 60 minutes, Exogenous intake of sodium bicarbonate less than 60 minutes ago (with the exception of an renal replacement therapy in place for more than 60 minutes)
  • Recent change in respiratory quotient: Change in enteral or parenteral nutrition solution for less than 3 hours
  • Pathology affecting CO2 metabolism: Fever\> 39 ° c, Intense chills.
  • Patients with unstable ventilation over the hour before inclusion.

Exclusion

    Key Trial Info

    Start Date :

    September 1 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2023

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT05430880

    Start Date

    September 1 2022

    End Date

    September 1 2023

    Last Update

    June 24 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpital Edouard Herriot, Anesthésie-réanimation

    Lyon, France, 69003